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Abstract: Cardiovascular magnetic resonance (CMR) imaging is the modality of choice for clinical studies of the heart 
and vasculature, offering detailed images of both structure and function with high temporal resolution. 
Small animals are increasingly used for genetic and translational research, in conjunction with models of common   
pathologies such as myocardial infarction. In all cases, effective methods for characterising a wide range of functional  
and anatomical parameters are crucial for robust studies. 
CMR is the gold-standard for the non-invasive examination of these models, although physiological differences, such as 
rapid heart rate, make this a greater challenge than conventional clinical imaging. However, with the help of specialised 
magnetic resonance (MR) systems, novel gating strategies and optimised pulse sequences, high-quality images can be  
obtained in these animals despite their small size.  
In this review, we provide an overview of the principal CMR techniques for small animals for example cine, angiography 
and perfusion imaging, which can provide measures such as ejection fraction, vessel anatomy and local blood flow,  
respectively. In combination with MR contrast agents, regional dysfunction in the heart can also be identified and   
assessed. We also discuss optimal methods for analysing CMR data, particularly the use of semi-automated tools for  
parameter measurement to reduce analysis time. Finally, we describe current and emerging methods for imaging the de-
veloping heart, aiding characterisation of congenital cardiovascular defects.  
Advanced small animal CMR now offers an unparalleled range of cardiovascular assessments. Employing these methods 
should allow new insights into the structural, functional and molecular basis of the cardiovascular system. 
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INTRODUCTION 
  Cardiovascular magnetic resonance (CMR) imaging has 
emerged as one of the most valuable tools for the diagnosis 
of heart disease. CMR is the only modality able to assess 
cardiac anatomy, function, viability, perfusion and metabo-
lism within a single non-invasive examination [1, 2]. Im-
provements in magnetic resonance (MR) scanner perform-
ance and hardware have rapidly increased the reliability and 
accuracy of clinical CMR. More recently, the introduction of 
parallel imaging and dynamic undersampling techniques has 
led to substantial accelerations in image acquisition to the 
extent that real time CMR is now possible. Such technology 
has opened up the opportunity to use magnetic resonance 
imaging (MRI) to guide interventional surgical procedures, 
in addition to further improving the spatial and temporal 
coverage in the most demanding techniques like first pass 
perfusion imaging. 
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  CMR in small animals, however, still remains a signifi-
cant technical challenge, primarily due to the spatial and 
temporal requirements. Applying MRI to a mouse heart, 
which can be less than one centimetre in length and beating 
in excess of 600 times per minute, requires specialist exper-
tise and equipment. Nevertheless, CMR still offers the most 
accurate means to measure cardiac function and provide un-
rivalled images of heart anatomy in vivo, allowing for serial 
non-invasive assessment of animals in cardiovascular re-
search [3, 4]. In this review we aim to provide an overview 
of the current CMR techniques routinely applied to experi-
mental models of cardiovascular disease in adult mice and 
rats, and additionally give an insight to some of the emerging 
techniques that may enable a greater range of possible CMR 
studies. 
1. TECHNICAL CONSIDERATIONS 
1.1. MR Acquisition and Hardware 
  CMR has transformed the way cardiac function can be 
assessed in small animals, where left ventricular (LV) struc-
ture, function, perfusion and viability can all be evaluated 
within one scanning session, while maintaining a high de-CMR Imaging in Experimental Models  The Open Cardiovascular Medicine Journal, 2010, Volume 4    279 
gree of accuracy and avoiding the harmful effects of ionising 
radiation and toxic contrast agents. Most cardiac MRI ex-
periments in small animals are performed using dedicated 
research scanners with a relatively small bore size (typically 
20-30cm) compared to clinical systems. The strength of the 
magnetic field used in MR scanners determines the amount 
of signal available from a given scan duration and for this 
reason field strengths of between 4.7 and 9.4T are commonly 
used for imaging small animals [5], although systems of up 
to 21.1T are now being installed [6]. High-field scanners are 
also equipped with high performance gradient systems which 
are needed to achieve the necessary image resolution. Never-
theless, small animal imaging has been successfully per-
formed on standard clinical systems using dedicated radio 
frequency (RF) coils, but inevitably the images produced   
do suffer from reduced signal associated with lower field 
strengths [7]. 
1.2. Physiological Monitoring and Gating 
  Unlike MRI of other anatomy, where the target organs 
are usually (or close to) stationary, the rapid movement of a 
beating heart poses a particular challenge in cardiac imaging. 
Motion is a fundamental vulnerability of MRI, and typically 
manifests as a ghosting artefact which can severely degrade 
image quality. While the normal range of resting heart rate in 
humans is 60-100 beats per minute (bpm), it can reach in 
excess of 600 bpm in small animals. Therefore, a technique 
for compensating the effect of cardiac motion is essential for 
successful cardiac MRI. Prospective electrocardiogram 
(ECG)-gating is one of the most established techniques used 
in both human and small animals. The principle of ECG gat-
ing is to use the ECG waveform, typically the R-wave peak, 
to trigger data acquisition, and thus synchronising images to 
a particular stage in the cardiac cycle. The result is an image 
of a “frozen” heart, built up from many cardiac cycles. The 
validity of this technique is therefore limited by the assump-
tion that there is negligible variation between heartbeats, 
which is true in most cases except in arrhythmias. Although 
the use of ECG-gating is well-established clinically, and can 
produce excellent results, specialised ECG equipment is re-
quired for use in small animals. These systems are designed 
to cope with the rapid heart rates, smaller ECG signals   
and increased electrical interference generated by the large 
gradient switching required to produce high resolution   
images. 
  Respiration is another source of undesired motion; the 
thoracic cavity and mediastinal organs such as the heart are 
displaced significantly during respiration. One solution is the 
use of MR navigator-echoes acquired during image acquisi-
tion to track the position of the diaphragm during respiration, 
allowing the subject to breathe freely throughout. However, 
with small animals it is most common to track respiratory 
movements via a neonatal apnoea pressure sensor placed 
over the chest or an inductive loop [8]. The combined car-
diac and respiratory signals provide the essential gating in-
formation needed to synchronise image acquisition and to 
also provide remote physiological monitoring of anaesthe-
tised animals within the scanner. 
1.3. Blood Flow Effects 
  Even with careful gating strategies, images can be   
degraded by fast flowing ventricular blood at certain parts of 
the cardiac cycle. Images can suffer from local signal losses 
or even more detrimental flow artefacts depending upon the 
speed of data acquisition. Fast MRI acquisition sequences, 
such as spoiled gradient echo (GRE), are required to image 
the heart with so-called bright blood contrast (as shown in 
Fig. 1). An alternative way of suppressing flow-induced arte-
fact is black-blood imaging, where the blood appears dark, 
which typically involves a double inversion preparation 
pulse prior to acquisition. This technique is particularly use-
ful for imaging structural abnormalities of the ventricles and 
pericardium. 
1.4. Pulse Sequences 
  In clinical cardiac MRI nearly all anatomical and func-
tional cardiac imaging is performed using either a segmented 
fast spoiled GRE sequence, or more recently, the steady-state 
free precession (SSFP) technique has become the gold stan-
dard. Segmented spoiled GRE images are primarily T1-
weighted and as a result the bright blood signal depends on 
fresh unsaturated (i.e. as yet unperturbed by RF energy) 
blood flowing through-plane to provide the contrast with the 
more saturated myocardium. SSFP on the other hand is 
somewhat independent to blood flow with image contrast 
dependent on the ratio T2/T1 and as a result provides excel-
lent blood-myocardium contrast even with slow moving 
blood [9]. In addition to the improved contrast, SSFP is also 
one of the most signal to noise ratio (SNR) efficient se-
quences, providing greater signal in less time than spoiled 
GRE images. Unfortunately, SSFP images suffer from band-
ing artefacts which are related to how short the repetition 
time can be made and the homogeneity of the magnetic field. 
As field inhomogeneity is directly related to field strength, it 
is extremely difficult to use SSFP for small animals at high 
fields. Thus, the primary sequence for assessing cardiac 
function in small animals is the original spoiled GRE used in 
the early days of human cardiac imaging. Following R-wave 
peak detection, a set number of echoes or k-space lines of 
data are acquired to make up the multiple frames of a cine 
image set. The process is repeated for many heart beats, 
typically 128 or 256 times, until all the data needed to recon-
struct a full cine image stack are acquired, creating a movie 
(or cine) of the beating heart. Standard image orientations of 
the heart consisting typically of a 2- and 4-chamber long axis 
view and, in order to calculate global function, a complete 
stack (from apex to base) of short axis images are acquired 
(see Fig. 1). 
1.5. Image Analysis  
  For almost all the animal models for which CMR is used, 
data analysis will be necessary to calculate functional pa-
rameters of the heart. Such parameters may be estimated for 
comparison at a single time point or for repeated measure-
ments in order to study disease progression or treatment re-
sponse. A typical CMR study will assess the standard global 
functional and morphological parameters of the heart, in-
cluding ejection fraction (EF), end-diastolic volume (EDV), 
end-systolic volume (ESV), stroke volume (SV), and left 
ventricular mass (LVM). Additional parameters such as 
myocardial perfusion, infarct size, myocardial strain, peak 
ejection and filling rates or the effect of agents such as dobu-
tamine may also be assessed. 280    The Open Cardiovascular Medicine Journal, 2010, Volume 4  Price et al. 
  Central to any CMR study is the analysis of cine data for 
the standard functional parameters. These are commonly 
calculated from a series of cine images taken from the apex 
to the base of the heart, which require accurate detection of 
the epicardial and endocardial borders (see Fig. 2). A clear 
set of rules for the inclusion of slices, maximum heart rate 
variability between slices, the handling of papillary muscles 
and the definition of the valve planes should be adapted to 
ensure accuracy, as well as low inter- and intra-observer 
variability. In addition, data should always be randomised 
and blinded before analysis to avoid observer bias. 
  In many published studies, papillary muscles are often 
not segmented as myocardium and treated as part of the 
blood pool. However, it can be argued that papillary muscles 
should be segmented as myocardium since they account for  
a sizable fraction of the blood-pool volume at end-diastole 
(up to 10%) [10]. This approach is commonly adopted due to 
its simplicity, as the geometry of the blood pool is made 
much simpler (i.e. circular) by omitting the papillary mus-
cles, thus making segmentation and measurement more time 
efficient. Nevertheless, the potential effects of omitting the 
papillary muscles on measurement accuracy should be   
considered during analysis, especially with estimation of 
ESV in which the LV blood-pool volume is lowest. 
  Manual segmentation of CMR data is commonly used 
and yields low inter- and intra-observer variability [3, 11]. 
The accuracy of heart volume measurements via MRI has 
been validated by comparing calculated myocardial mass 
and ex vivo measurements, showing a high correlation be-
tween both methods [3, 12, 13]. 
  The increasing demand for CMR and the time consuming 
nature of manual segmentation has lead to development of 
commercially available semi-automatic segmentation meth-
ods. These may offer a considerable reduction in analysis 
time while showing similar inter- and intra-observer variabil-
ity [11, 14]. Such segmentation programs use different   
approaches from simple thresholding to more advanced de-
formable models for volume estimation and generally include 
long axis views to improve valve definition accuracy. 
2. TECHNIQUES FOR ASSESSING CARDIAC 
PHYSIOLOGY 
2.1. Myocardial Mass 
  Myocardial mass, or left ventricular (LV) mass in par-
ticular, is an important index for the assessment of cardiac 
functional status for a variety of clinical conditions such as 
cardiomyopathy, hypertension, and valvular disease. MRI 
can be used to quantify myocardial mass by acquiring a vol-
ume dataset of the heart. A delineation of the epicardial and 
endocardial contours of the left ventricle is performed, after 
which the segmented volume is multiplied by the myocardial 
specific gravity (1.05 g/cm
3) to calculate the LV mass. Accu-
rate in vivo quantification of myocardial mass using MRI has 
been demonstrated and validated in the mouse and rat [4, 15, 
16]. Clinically, MRI has been shown to be more accurate and 
reproducible than M-mode, 2D and 3D echocardiography 
[17-19]. 
2.2. Wall Motion 
  Global and local myocardial motion can be assessed by 
myocardial tagging strain analysis, using sequences such as 
spatial modulation of magnetisation (SPAMM) or phase con-
trast MRI [20]. In SPAMM, spatially selective RF pulses are 
applied to pre-saturate thin planes of myocardium perpen-
dicular to the imaging plane at end-diastole (see Fig. 3), which 
are then used as markers for regional myocardial movements 
[21, 22]. MRI tagging can be applied in two or three dimen-
 
Fig. (1). Example of bright blood cine images of a rat heart at 9.4T. Standard orientations consisting of two and four chamber long-axis and 
short-axis views are acquired. The upper row shows corresponding images for end diastolic (ED) time frame and the lower row end systolic 
(ES) time point. la: left atrium, mv: mitral valve, lv: left ventricle, ra; right atrium, rv: right ventricle, lvw: left ventricular wall, rvw: right 
ventricular wall, pap: papillary muscle. The scale bar represents 1 cm. CMR Imaging in Experimental Models  The Open Cardiovascular Medicine Journal, 2010, Volume 4    281 
sions to assess radial, circumferential and longitudinal short-
ening [23, 24]. The pre-saturated thin planes, or tags, appear 
dark on the image and persist throughout a cardiac cycle. 
During myocardial contraction, these tags are displaced in 
accordance to their underlying myocardial motion. The de-
grees of displacement are then used to evaluate myocardial 
contractility using tag detection and displacement-estimation 
algorithms [25, 26]. Myocardial displacement is calculated 
and reconstructed in three dimensions to provide detailed strain 
maps of the tagged myocardium in relation to time and space 
[24]. Although an accurate assessment of three-dimensional 
LV function can be obtained with this technique, data analy-
sis is slow and can require significant user input [27]. 
  Faster data processing and image acquisition techniques 
such as; harmonic phase, displacement encoding with stimu-
lated echoes [28], and fast strain-encoded MRI [29] are 
emerging. Harmonic phase MRI utilises the phase compo-
nent of images acquired with SPAMM, which contains an 
array of harmonic (or spectral) peaks in the Fourier domain. 
A single off-centred peak contains motion information, 
where the phase of a complex image (inverse Fourier trans-
form) of such a peak is linearly related to the true motion 
[30]. By isolating these peaks, the motion of the underlying 
tissue could be tracked automatically with great accuracy 
[31]. 
  Myocardial tagging has been validated in a canine model 
with sonomicrometry [32], and was used to evaluate   
myocardial strain during local ischaemia in dogs [30, 33]   
and after myocardial infarction in rats [27]. It has also been 
applied to characterise regional myocardial function in the 
 
Fig. (2). Segmentation of a typical cine stack of a rat heart. The red line delineates the endocardial border, whilst the green line marks the 
epicardial border. The top and bottom rows depict the end diastolic (ED) and end systolic (ES) time frames, respectively. The columns show 
different slices where the most apical slice included is labelled as slice 1 (S01). Parameters; in-plane resolution: 200x200 m, slice thickness 
1 mm, RV: right ventricle, LV: left ventricle. 
 
Fig. (3). Myocardial tagging in the mouse. Four chamber, two chamber and short-axis views of a mouse heart at end diastole are shown in 
the top row, while end systolic frames are depicted in the lower row. The movement of the tagged myocardial tissue can be tracked to calcu-
late myocardial strain. The scale bar represents 5 mm. 282    The Open Cardiovascular Medicine Journal, 2010, Volume 4  Price et al. 
mouse [23] and to demonstrate that left ventricular torsion  
is equal in mice and humans [34]. 
2.3. Perfusion 
  Perfusion measurement plays an important role in early 
detection of occlusive coronary heart disease, as well as de-
termining the severity of occlusion and viability of myocar-
dium [35]. A characteristic feature of occlusive coronary 
heart disease is the reduction in myocardial flow reserve, 
which can be detected before clinical symptoms or LV dys-
function become evident [36]. Currently, there are two main 
techniques for perfusion studies: Arterial spin labelling 
(ASL) and contrast-enhanced first-pass perfusion imaging. 
  The first-pass perfusion technique tracks the transit of 
blood by using gadolinium-based contrast agents; gadolin-
ium is paramagnetic and shortens T1 relaxation, thus giving 
higher signal intensity in T1-weighted images. During a first-
pass perfusion scan contrast agent is injected peripherally, 
which then passes through the venous system into the heart 
chambers. A fast (single-shot) T1-weighted sequence is used 
to image the myocardium as the contrast agent reaches the 
coronary arteries and perfuses through, with enhancement 
peaking approximately 10 heartbeats after passing the LV 
chamber [37]. Signal intensity correlates with contrast con-
centration, and hypo-enhanced areas indicate reduced or no 
tissue perfusion. The technique is well-established clinically 
and is the most practical method for evaluating myocardial 
perfusion [37], however it remains a significant challenge for 
use in small animals. In order to capture the arrival of the 
first-pass of contrast agent, complete image frames need to 
be acquired in a relatively motion-free portion of the cardiac 
cycle, so for mice this could be in the order of 10-30 ms. In 
addition, reproducible bolus injections are hard to achieve in 
small animals, making accurate quantitative perfusion stud-
ies extremely difficult to perform [5, 38]. 
  Alternatively, arterial spin labeling (ASL) may be used to 
non-invasively quantify perfusion. ASL perfusion measure-
ments are generated by the comparison of two T1 maps: i) 
using a global inversion recovery and ii) with a slice-
selective inversion recovery for a slab slightly larger than the 
imaging slice. In the slice-selective case, spins (proton sig-
nal) that enter the imaging slice due to perfusion are not in-
verted, causing an apparent acceleration in T1 recovery. An 
assessment of the difference between the global and slice-
selective T1 maps provides a quantification of the blood per-
fusion in the imaging slice. Fig. (4) displays T1 maps gener-
ated by global and slice-selective inversion and a perfusion 
map for a mouse at baseline under general anaesthesia. 
  This technique has been adapted for use in the myocar-
dium of mice and rats in a limited number of studies (se-
quences are presented in [39-41]). Blood flow values have 
been found to be comparable with microsphere measure-
ments [41-43], although low SNR and speed are the main 
limitation of this technique. To date, ASL has been used to 
assess perfusion in a diverse range of applications, including 
myocardial infarction models [41], nitric oxide synthase 
knockout mice [44], dobutamine stress tests [40], vasodilata-
tion tests and effects of a variety of anaesthetics [44-46]. 
  Another technique, widely used in functional neuroimag-
ing, is blood oxygen level dependent (BOLD) imaging, and 
has been applied to assess myocardial perfusion [47]. Tradi-
tional BOLD imaging is based on T2*-weighted sequences as 
previous research in the brain has shown T2* to be more sen-
sitive than T2 to changes in oxygen saturation [48]. However, 
T2*-based BOLD cardiac imaging poses significant prob-
lems due to local field inhomogeneities, exacerbated by the 
susceptibility of a GRE sequence with long echo times [49]. 
Alternatively, T2 could be used, but is less sensitive to oxy-
gen saturation changes. By using a T2-prepared SSFP BOLD 
sequence, Shea et al. demonstrated a good correlation   
between changes in signal intensity and myocardial blood 
flow [49]. 
2.4. Viability 
  Myocardial viability is defined as the presence of living 
(or viable) myocytes, and is an important index in assessing 
the extent of post-ischaemic injury. It is important to note 
that a portion of myocytes might have impaired contractility 
after an ischaemic assault, possibly due to reduced perfusion, 
but are still alive. These cells are known as hibernating myo-
cytes and their functionality is potentially fully recoverable 
when normal myocardial blood flow is restored. Two fre-
quently used clinical MRI techniques, dobutamine stress and 
late gadolinium enhancement, offer the means to differenti-
ate between hibernating and non-viable myocytes.  
  In dobutamine stress MRI, a series of cine images are 
acquired while increasing doses of dobutamine, an inotropic 
agent, are infused into the subject (see Fig. 5). Any akinetic 
or dyskinetic myocardial segments that are viable (ie. con-
tain hibernating myocytes) would show an improvement in 
contractility after administration of dobutamine. This tech-
 
Fig. (4). ASL perfusion imaging in the mouse. Short-axis image (a), T1 maps from global inversion (b) and slice-selective inversion (c) are 
used to generate the perfusion map (d) obtained from a mouse at baseline. CMR Imaging in Experimental Models  The Open Cardiovascular Medicine Journal, 2010, Volume 4    283 
nique has been shown to adequately predict improvement in 
LV function in patients after revascularisation [50], and was 
employed to investigate acute and chronic cardiac remodel-
ling after MI in mice and rats [51, 52]. Myocardial tagging 
can be incorporated into dobutamine stress MRI and has 
demonstrated superior accuracy over studies without tagging 
[53], and produced similar accuracy to dobutamine stress 
echocardiography (DSE) [54]. Currently, there are still only 
a limited number of experimental studies that have utilised 
dobutamine stress MRI in small animals [16, 44, 51, 55]. 
  The other approach for assessing myocardial viability is 
delayed enhancement MRI or late gadolinium enhancement 
(LGE) which involves administering a contrast agent to   
directly image non-viable myocardium (see Fig. 6). In this 
method, an extracellular contrast agent (usually Gd-DTPA) 
is injected into the subject. On first-pass images, normal 
myocardium with normal perfusion would be enhanced by 
the contrast agent, whereas infarcted regions would appear 
hypoenhanced due to reduced or absent perfusion. However, 
the hypoenhanced region would gradually become hyperen-
hanced as a consequence of increased retention of contrast 
agent, which is thought to be caused by increased extracellu-
lar matrix within collagenous scar, and delayed washout due 
to reduced capillary density [56]. This method is well-
validated clinically for predicting the distribution of infarc-
ted myocardium [57] and for excluding irreversible damage 
where no delayed enhancement is observed [58, 59]. It is 
also well-validated in a mouse occlusion/ reperfusion model 
with 2,3,5-Triphenyltetrazolium chloride staining [60], but 
results are varied in the rat model [5]. 
  Manganese-enhanced MRI (MEMRI) is an alternative 
technique used in experimental cardiac studies. Similar to 
Gd agents, Mn
2+ is also paramagnetic and primarily acts by 
reducing T1 of surrounding tissue to cause signal enhance-
ment on MR images. However, its strength in small animal 
studies is its use as a molecular agent, since Mn
2+ ions have 
physical properties similar to calcium ions, and therefore 
taken up by excitable cells such as neurons and cardiomyo-
cytes where Ca
2+ influx readily occurs. In cardiomyocytes in 
particular, Mn
2+ is able to enter the cell through voltage-
gated calcium channels. However, in contrast to Ca
2+, Mn
2+ 
is retained after uptake, which can lead to cardiotoxicity. 
 
Fig. (5). Assessment of pharmacological agents on cardiac function in a normal mouse. Baseline images (first column) acquired prior to an 
infusion of dobutamine (middle column). In addition, the effect of the beta blocker esmolol (right column) is subsequently shown to counter-
act the increased contractility caused by the cardiac stress agent dobutamine. ED; end diastolic, ES; end systolic time frames. The scale bar 
represents 5 mm. 
 
Fig. (6). Late gadolinium enhancement MRI in a rat 2 hours following surgery to induce myocardial infarction. A series of consecutive short-
axis images reveal a large area of non-viable myocardium extending down to the apex. Imaging was performed ~10 minutes following injec-
tion of Gd-DTPA. From reference [61]. 284    The Open Cardiovascular Medicine Journal, 2010, Volume 4  Price et al. 
  The key use of MEMRI in cardiac imaging is to produce 
a signal enhancement on MRI that relates to cardiac func-
tion. In the mouse heart, MEMRI has been shown to be sen-
sitive to inotropic changes [62]. Administering Mn
2+ by in-
travenous infusion, forming a stable plasma concentration 
allows baseline signal intensity measurement to be taken. 
After administration of a inotropic agent, such as dobu-
tamine, MRI signal can be seen to increase in more active 
areas of myocardium. Similarly, in animal models of myo-
cardial infarction, Mn
2+ may also be used to delineate be-
tween infarcted and healthy myocardium on the basis that 
uptake of Mn
2+ is greater in regions of functioning tissue 
where viable cardiomyocytes are abundant.  
2.5. Angiography 
  Magnetic resonance angiography (MRA) in small ani-
mals is most commonly performed using the time-of-flight 
(TOF) approach [63-65]. The technique relies on the same 
contrast mechanism utilised in bright blood imaging, but 
typically 3D images are collected from multiple acquisitions 
of overlapping thick slabs rather than 2D slices. Vascular 
anatomy can then be visualised with rendered maximum 
intensity projection 3D volumes (see Fig. 7). Most applica-
tions of small animal MRA have been limited to cerebro-
vascular anatomy, applying the technique to the vessels sur-
rounding the heart is particularly challenging. However, 
there have been reports of using TOF MRA to visualise even 
the coronary arteries in the living mouse [66]. Low-doses of 
gadolinium contrast agents can be used to further enhance 
the TOF effect and improve image quality. They can be used 
to reduce the overall acquisition time which can be particu-
larly long when cardiac and respiratory gating is used, which 
is essential for visualising the smaller vessels located close 
to the heart [67]. 
 
Fig. (7). In vivo magnetic resonance angiography of an adult mouse 
showing the major vessels superior to the base of the heart. TOF 
techniques provide high contrast between flowing blood and sur-
rounding tissue, image data can be reconstructed using maximum 
intensity projection to give 3D renders of vessel geometry. 
2.6. Vessel Wall and Plaque Imaging 
  Vessel wall imaging in small animals remains challeng-
ing due to the extremely high resolution required. Ohlstein  
et al [68] and Chandra et al [69] performed in vivo (at 4.7T) 
and ex vivo (at 9.4T) carotid artery imaging in rats. In these 
ex vivo studies, the various layers of the arterial wall were 
clearly defined. In vivo vessel wall imaging of the mouse 
common carotid artery was performed in another study [70] 
by using a composite image-reconstruction method, where 
T1, T2 and PD-weighted images were assigned a separate 
colour channel, and combined to form a 24-bit colour image. 
The resultant contrast made the vessel wall distinguishable, 
but not sufficient for accurate measurements. In another 
study, the mouse coronary arteries and the four valves were 
successfully imaged in vivo, without the aid of contrast 
agents [66]. Vessel wall and plaque imaging have also   
been performed in other knockout mouse models [71-74]. 
Targeted contrast agents like SPIOs (super-paramagnetic 
iron oxide particles) conjugated to antibodies can be used   
to image specific molecular processes involved in disease 
progression [75].  
2.7. Myocardial Micro- and Macro-Structure 
  Diffusion tensor imaging (DTI) has the potential of char-
acterising the remodelling of cardiac fibre structure after 
infarction in rats, and is based on the theory that water   
diffusion will be the greatest parallel to the myocardial fibre 
orientation, and therefore the primary eigenvector of the   
diffusion tensor coincides with the local fibre orientation. By 
comparing DTI and conventional histological results, recent 
studies using dogs, goats and rabbits [76-78] have demon-
strated a good correlation between MRI and histological   
fibre angle measurements, thereby validating the DTI   
approach for complete characterisation of myofibre architec-
ture. MR-microscopy and diffusion imaging have also been 
performed on isolated and fixed rat hearts [79-82]. DTI may 
potentially be a valuable tool for defining structural remodel-
ling in diseased myocardium at cellular and tissue levels.  
2.8. Metabolic Characterisation 
  MR spectroscopy is a technique which can non-
invasively measure the relative concentrations of molecules. 
It can be used to characterise the concentrations of high en-
ergy phosphorous compounds involved in cardiac energy 
metabolism for a selected region of the myocardium. Phos-
phorus molecules of interest are adenosine triphosphate 
(ATP), phosphocreatine (PCr) and inorganic phosphates (Pi). 
Myocardial ischaemia leads to a significant reduction in the 
PCr/Pi ratio, as well as a reduction in the PCr/ATP ratio. 
31P 
MR spectroscopy has been demonstrated to be feasible for 
measurements of the PCr/ATP ratio in isolated mice hearts 
[83, 84]. Concentration of intracellular sodium is another 
indicator for myocardial ischaemia, and could be distin-
guished from extracellular sodium using 
23Na MRI with 
chemical shift imaging [85]. Cardiac metabolic imaging of 
other nuclear magnetic resonance-visible nuclei such as 
13C 
and 
19F have also been investigated, but experience in this 
field is still limited [86, 87] and is particularly challenging to 
implement successfully. 
3. EXPERIMENTAL ANIMAL MODELS OF   
CARDIOVASCULAR DISEASE 
3.1. Myocardial Ischaemia 
  Myocardial ischaemia occurs when there is an imbalance 
between myocardial oxygen supply and consumption due to 
reduced coronary blood flow [88], which if not restored CMR Imaging in Experimental Models  The Open Cardiovascular Medicine Journal, 2010, Volume 4    285 
promptly would ultimately lead to infarction of myocardium. 
Clinically, myocardial ischaemia is most commonly caused 
by thrombotic occlusion of a coronary artery, which is initi-
ated by the rupture of an atherosclerotic plaque. Since this is 
a spontaneous process, it is difficult to mimic; therefore 
myocardial ischaemia in most animal models is achieved by 
occluding the coronary arteries mechanically either by direct 
ligation or intraluminally, with the former being the most 
popular technique in small animals including mice and rats, 
and the latter method largely confined to bigger animals such 
as dogs and pigs [89]. With the direct ligation method, the 
animal is anaesthetised and ventilated, after which the heart 
is exposed typically via a left thoracotomy. The left anterior 
descending coronary artery (LAD), which supplies the   
anterolateral region of the left ventricle, is then ligated using 
sutures and a snare. Successful occlusion is evident by the rapid 
pallor over the anterolateral region of the left ventricle that is 
perfused by the LAD, as well as associated ECG changes. 
  The evolution of ischaemia to infarction and subsequent 
ventricular remodelling is characterised by the progression 
of injured myocardium to fibrosis and corresponding wall 
thinning. Compensatory hypertrophy of the remote healthy 
myocardium may follow, after which the infarcted heart may 
then progressively dilate and eventually undergo failure [90]. 
By using animal models, the site, duration and degree of 
coronary occlusion can be manipulated to alter the character-
istics of the resulting ischaemia and infarction, and therefore 
allowing the different stages of myocardial infarction to be 
studied. Different variants of myocardial infarction models 
will be discussed below. 
3.1.1. Ischaemia without Reperfusion (Permanent   
Occlusion) 
  In a permanent occlusion model, the LAD artery is 
ligated permanently with a silk suture and therefore the 
ischaemic myocardium is not reperfused. As a result, infarc-
tion is often more extensive and transmural in nature, and 
subsequent fibrosis and wall thinning is achieved more rap-
idly (see Fig. 8). This approach is thus valuable for investi-
gating the later stages of myocardial infarction, such as ven-
tricular remodelling and heart failure [91]. 
3.1.2. Ischaemia with Reperfusion (Transient Occlusion) 
  This approach involves a transient period of ischaemia 
followed by the release of ligation to allow reperfusion of  
the previously ischaemic myocardium (example shown   
in Fig. 9). Transient occlusion represents more closely the 
ischaemia-reperfusion scenario that is found clinically, where 
patients are revascularised following an acute ischaemic 
event. Therefore, the ischaemia-reperfusion model is popular 
amongst interventional studies, including those using statins 
[92] and stem cell therapy [93]. In addition, the ischaemia-
 
Fig. (8). Permanent occlusion model of myocardial ischaemia in the mouse. Late gadolinium images shown here are acquired 48hrs after 
myocardial infarction (MI) surgery with 3 consecutive short-axis slices (a), and a 4-chamber long-axis view (b), revealing myocardial 
ischaemic region and the early stages of wall thinning (figures from reference [61]). 
Fig. (9). Example of reperfused MI in a rat. Images of the infarcted heart were acquired two hours after reperfusion of the occluded left ante-
rior descending coronary artery. The size of the infarcted myocardium can be roughly estimated via reduced contractility on short axis views. 
Late gadolinium enhancement (LGE) (far right) can be used for accurate assessment of the infarct size. The size changes associated with cell 
death are exploited with this method and can be seen as enhancement of the myocardium. ED; end diastolic and ES; end systolic time points. 
The scale bar represents 1 cm. 286    The Open Cardiovascular Medicine Journal, 2010, Volume 4  Price et al. 
reperfusion model is also valuable for investigating reperfu-
sion injury, a phenomenon believed to contribute to further 
myocardial damage following reperfusion [94]. 
3.2. Atherosclerosis and Vascular Injury Models 
3.2.1. Atherosclerosis Models 
  Atherosclerosis, a precursor of myocardial infarction and 
stroke, is a common inflammatory disease of complex 
pathogenesis and multiple factors such as thrombosis, hyper-
lipidaemia and endothelial injury. It is characterised by the 
accumulation of lipids and fibrous components, the recruit-
ment of monocytes and lymphocytes, and hyperplasia of 
media, all of which contributing to the subsequent thickening 
and reduced elasticity of the arterial wall [95]. The rabbit  
is one of the most investigated animals in atherosclerosis 
research, since they develop spontaneous or high-lipid   
diet-induced atherosclerotic plaques [96]. While rodents   
are naturally resistant to atherosclerosis, several transgenic 
mouse strains such as the apoprotein-E knockout have been 
developed to introduce lipid abnormalities and subsequently 
atherosclerosis [97]; such techniques offer the potential to 
study the role of isolated metabolic pathways in atheroscle-
rosis. 
  The stability of an atherosclerotic plaque is an important 
factor, since vulnerable plaques – characterised by a thin cap 
and large lipid core – are prone to rupture, where the ensuing 
thrombosis is often the cause of coronary occlusion [98]. 
Therefore, the ability to differentiate between stable and vul-
nerable plaques is of great clinical relevance; however, there 
is currently no robust biomarker to distinguish between the 
two due to their similar composition and pathophysiology. 
Recently, imaging techniques such as intravascular ultra-
sound and high-resolution MRI have provided some prom-
ises in identifying vulnerable lesions in the clinical settings 
[70, 99]. 
3.2.2. Endothelial Injury and Restenosis Models 
  Localised arterial wall and endothelial injury can be pro-
duced by mechanical means to investigate restenosis (re-
narrowing of the vessel) in animal models. This disease is 
associated with transluminal angioplasty, a technique widely 
used for coronary revascularisation following myocardial 
infarction, where a small balloon is inserted and inflated to 
expand the occluded artery. The procedure invariably causes 
injury to arterial wall and in particular endothelial denuda-
tion, triggering cell proliferation, intimal thickening and ul-
timately restenosis that may require repeated treatment. In 
rats, the common carotid artery is often used to create endo-
thelial injury due to its accessibility and size [100]. Assess-
ment of injury and disease progression in this model have 
traditionally relied on histopathological analysis with cross-
sectional slides [101]; increasingly, standard MRI and MRA 
techniques as well as the more novel MR microscopy and 
contrast agents are being used to assess the vessel wall and 
quantify the degree of restenosis in addition to histology [68, 
69, 102, 103].  
3.2.3. MR Assessment of Cellular Therapies  
  The discovery of stem cells and their potential for tissue 
regeneration led to the hypothesis that regeneration of the 
adult damaged heart might be possible via stem cell trans-
plantation. It is hoped that stem cells will differentiate into 
cardiomyocytes or fuse with resident myocytes and func-
tionally integrate if they receive the right clues from their 
microenvironment. Following this hypothesis many studies 
in animals [104-112] and a few clinical trials [112-114] have 
been conducted. Some of the cell transplantation studies in 
small animals showed considerable improvement in cardiac 
function while others showed only mild improvements. 
However, these improvements could not be translated into 
human trials. It is, therefore, necessary to improve the animal 
models in order to derive clinically relevant information 
from them. These studies employed different analysis meth-
ods such as MRI, PET and echocardiography which is 
probably one of the sources for variability. 
  Another problem with small animal models is the quanti-
fication of the amount of cells and their specific localisation. 
MRI together with stem cells labelled with superparamagnetic 
iron oxide particles (SPIOs) can be used to address these 
issues. SPIOs generate local field inhomogeneities when 
placed into a magnetic field. This causes local hypointensity 
(darkness) in T2 or T2
* weighted MR images (see Fig. 10). 
The sensitivity of T2
* images to SPIOs allows the detection 
of a few thousand cells or even single cells [115-119]. Sev-
eral publications indicate that the labelling of stem cells with 
small amounts of SPIOs does not alter their viability and 
differentiation potential [120-122]. However, there is always 
the possibility of functional changes. Therefore, a careful 
optimisation of the labelling strategy should be performed 
before it is used in vivo. SPIO labelled cells offer the possi-
bility to confirm the delivery success of a particular strategy 
and allow the tracking of cell movement over time.  
 
Fig. (10). Short axis view of a rat heart: mid-ventricular slice at end 
systolic time point. The arrow points to the hypointense region 
where stem cells were injected one week prior to image acquisiton 
into the border region of an infarct. T2
* weighted spoiled GRE 
sequence used. 
  The quantification of delivery success is important to 
establish if there is a dose dependent relationship between 
the amount of cells delivered and the functional outcome of a 
study. However, this has to be done with caution. Firstly, 
imaging artefacts which cause hypointense regions are fre-
quently observed on cardiac cine images. Secondly, the hy-
pointensity observed from SPIOs is only indirectly coupled 
to the cells administered in particular over a long time 
course. SPIOs are frequently taken up by neighbouring cells 
and macrophages when cells die. As long as those cells and 
macrophages stay in the same imaging voxel they cannot be 
differentiated from the transplanted cells. A major limitation 
of SPIO based cell tracking is the inability to assess cell   CMR Imaging in Experimental Models  The Open Cardiovascular Medicine Journal, 2010, Volume 4    287 
viability. It might, therefore, be necessary to use an addi-
tional labelling strategy which allows assessment of cell vi-
ability over time. Depending on the method, it might allow 
for the combination of high spatial resolution MRI with in 
vivo cell viability assessment. 
4. IMAGING THE DEVELOPING HEART WITH MRI 
4.1. Ex Vivo Morphological Phenotyping of Mouse Models 
  Since the early part of the 20
th century, mice have been 
used widely for genetic investigations [123] and more re-
cently methods have emerged to enable direct manipulation 
of the mouse genome. The mouse has become the key model 
for research into human disease. With the announcement of 
the completion of the first draft of the mouse genome in 
2002 [124], a number of large-scale programmes are under-
way to systematically create transgenic knockout models 
[125]. The study of the embryos of such mouse mutants is 
useful to determine effects of genes on development and 
congenital disease. Given the commonality in molecular 
pathways across the embryo, insight may be obtained into 
novel genes involved in the basis of heart development. The 
study of the effect of genes on mouse embryo development 
is particularly relevant to the investigation of congenital 
heart defects (CHDs). 
  Morphological analysis of embryo anatomy is an impor-
tant part of phenotype characterisation. Conventionally, this 
is done ex vivo by microscopic examination with histology. 
In this method, embryos are ethanol-dehydrated, embedded 
in paraffin wax and thinly sectioned into 2-8m slices [126]. 
This provides high resolution 2D data and sections that may 
also be stained for gene and protein expression. A recent 
refinement of this process is episcopic imaging, where the 
autofluorescence of each histology section can be photo-
graphed and combined computationally to generate high 
resolution 3D volume datasets (typically 1-2m isotropic 
resolution) [127, 128]. However, these histological ap-
proaches are time-consuming and do not lend themselves 
readily to rapid screening as only one embryo may be im-
aged at a time. Non-invasive imaging methods, such as MRI, 
have the potential to offer large time advantages and are in-
creasingly used as an adjunct to histology in the examination 
of embryo phenotype. This is particularly important consid-
ering the large number of embryos required to characterise a 
phenotype. 
4.2. Non-Destructive Imaging in Ex Vivo Embryo   
Phenotyping 
  Due to the generally low-volumes of embryos that may 
be phenotyped with conventional histology and its destruc-
tive effects on tissue morphology, there is interest in utilising 
non-invasive imaging methods for morphological screening. 
Microscopic MRI (MRI) is one such imaging method, al-
lowing assessments of both embryo development [129] and 
phenotype [130]. 
  The use of high-resolution MRI for cardiovascular phe-
notyping was initiated in the 1990s by Smith and colleagues 
[131], where they developed a technique to image embryo 
vasculature. Later, Jacobs and colleagues produced high 
resolution MR images of single embryos [132], with the goal 
of creating 3D anatomical atlases as an advance over the 2D 
histology-based atlases [126] commonly used, although with 
a long scan time per embryo. This work has recently been 
extended by Petiet et al. who produced a database of embry-
onic, neonatal and adult mice imaged at a number of devel-
opmental time points using their method to characterise heart 
phenotypes in mid-gestation embryos [129, 130]. 
4.3. MRI of Multiple Embryos 
  Techniques have also been developed to image multiple 
embryos, in a single acquisition [133]. This method has re-
cently been optimised for cardiac phenotyping in developing 
embryos [134] and can allow for up to 40 embryos to be im-
aged in a single 10-hour scan, through the use of a customised 
imaging coil. In this method, embryos are dissected from the 
mother and fixed for at least two weeks in a solution of for-
maldehyde and an MR contrast agent, such as Gd-DTPA. 
The use of these agents as so-called active stains for ex vivo 
tissue [135], boosts SNR and enhances image quality when 
performing MRI. This SNR improvement is important for 
embryo imaging as their small size requires very high resolu-
tion datasets (< ~50m isotropic), which can take days to 
acquire without active staining. As the agent is given suffi-
cient time to penetrate fully into embryo tissues, tissue T1 
relaxation time is reduced, allowing shorter scan-times to be 
used without affecting SNR and thus image quality. An iso-
tropic 3D dataset is then acquired that may be sliced arbitrar-
ily and viewed in any direction. An outline of the imaging 
process is shown in Fig. (11). The detailed heart anatomy 
seen in typical MR images is shown in Fig. (12).  
Fig. (11). Outline of the high-throughput embryo imaging process. From left to right: multiple embryos can be embedded into a centrifuge 
tube and imaged overnight (52m isotropic resolution). A 3D volume is then produced which can then be viewed at any angle. A sagittal 
slice from a single embryo shows the quality of anatomical detail in resulting images. 288    The Open Cardiovascular Medicine Journal, 2010, Volume 4  Price et al. 
 
Fig. (12). Normal mouse embryo heart anatomy at 15.5 days post 
coitum (dpc) as seen by MRI. a-d show successive axial slices 
through the thorax at the levels indicated. Key: Tr=Trachea, 
Th=Thalamus, AA=Ascending Aorta, PA=Pulmonary Artery, 
L.SVC=Left Superior Vena Cava, LA=Left Atrium, RA=Right 
Atrium, LV=Left Ventricle, RV=Right Ventricle. Note: dimension 
of heart is approximately 2 mm in diameter. 
4.4. Phenotyping of the Chd7 Model of Charge Syndrome 
  Cardiac phenotypes can be identified with the multi   
embryo MRI technique. One example is screening of Chd7 
heterozygous embryos [134]. CHD7 is a transcription factor 
implicated in CHARGE syndrome [136] – a condition with 
an incidence of 1 in 10,000, partly characterised by defects 
the cardiovascular system. Ventricular septal defects were 
identified using MRI in heterozygous mice (Fig. 13), as seen 
in axial images and volume rendering; great vessels are also 
readily visible allowing phenotypes in these regions to be 
identified. 
4.5. Future Direction of Embryo Phenotyping Using MRI 
 In  vivo imaging in utero with MRI has been reported 
[137, 138] and is able to show structural images of embryos 
within the mother. However, the continuous foetal motion 
requires relatively short scans to be taken to reduce move-
ment artefacts in the image. This places a limit on the 
achievable resolution (typically ~150um in-plane), signal 
and contrast to noise. An additional difficulty for the assess-
ment of cardiac function in embryos has been the synchroni-
sation of the image acquisition with the cardiac cycle. Recent 
developments have enabled the acquisition of 3D cine 
datasets of the embryo heart in vivo [139]. Manganese, 
which is increasingly used as an MRI contrast agent in pre-
clinical brain studies for activation and tract-tracing applica-
tions, has been applied to the embryo [140]. Its use, in con-
junction with in utero MRI, could offer functional informa-
tion to future embryo heart studies. 
  A full comprehensive analysis of cardiac phenotype and 
development in embryos will continue to need a complemen-
tary set of imaging modalities ranging from optical micros-
copy to MRI and ultrasound. The strength of MRI, currently, 
is its ability to rapidly create non-invasive 3D datasets of 
multiple embryos without distortion and with good delinea-
tion of soft tissue and vascular anatomy. However, the tradi-
tional strength of MRI has been its capability to perform 
longitudinal studies, where changes in an individual animal 
may be followed over time. With advances in in utero tech-
niques it may soon be possible to carry out a temporal char-
acterisation of heart development from embryo to adult.  
5. CONCLUSION 
  The challenge for cardiac imaging is the accurate as-
sessment of cardiac structure and function in a non-invasive 
fashion with high temporal and spatial resolution. Ideally, 
techniques should be widely available, suited to both ex-
perimental and clinical conditions, and applicable to a vari-
ety of physiological and pathological states. Cardiac MRI 
techniques have become important tools in the research envi-
ronment with a steadily increasing number of research facili-
ties implementing CMR. 
  It is clear that these imaging techniques provide a broad 
range of measures of cardiac integrity that are related to the 
functional status of the tissue. One of the major advantages 
of CMR is its non-invasive nature which lends itself to re-
peated assessment of cardiac function in the same animal. 
This allows the tracking of pathological changes over time 
and as the same animal is used repeatedly increases the sta-
tistical power to detect differences. This unique information, 
in the form of high resolution structural and functional im-
ages of the heart, may lead to better understanding of cardiac 
pathologies and potential treatment strategies. Additionally, 
using techniques from the clinical setting should help to im-
 
Fig. (13). Axial slices through Chd7
+/+ and Chd7
+/- embryos as part of a high throughput MRI screen. (a) Image showing a wild-type embryo 
with an intact ventricular septum. (b) image from an Chd7
+/- embryo showing a ventricular septal defect (VSD) which was confirmed  
on later H&E histology (c) [134]. Volume rendering (d) of the same Chd7
+/- heart and great vessels allows visualisation of the VSD  
(red triangle) in 3 dimensions. CMR Imaging in Experimental Models  The Open Cardiovascular Medicine Journal, 2010, Volume 4    289 
prove the applicability of experimental findings to human 
patients. 
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ABBREVIATIONS 
3D =  Three  dimensional 
ASL  =  Arterial spin labelling 
ATP =  Adenosine-5'-triphosphate   
BOLD =  Blood-oxygen-level  dependent 
CMR  =  Cardiac magnetic resonance 
DTI  =  Diffusion tensor imaging 
ECG =  Electrocardiogram 
ED =  End-diastole   
EDV =  End-diastolic  volume 
EF =  Ejection  fraction 
ES =  End-systole 
ESV =  End-systolic  volume 
Gd-DTPA = Gadopentetate  dimeglumine 
GRE =  Gradient  echo 
LAD  =  Left anterior descending coronary artery 
LGE  =  Late gadolinium enhancement 
LV =  Left  ventricle 
LVM  =  Left ventricular mass 
MEMRI  =  Manganese enhanced magnetic resonance 
imaging 
MI =  Myocardial  infarction 
MR  =  Magnetic resonance  
MRA  =  Magnetic resonance angiography 
MRI  =  Magnetic resonance imaging 
PCr =  Phosphocreatine 
Pi =  Inorganic  phosphates 
RF =  Radio  frequency 
SNR  =  Signal to noise ratio 
SPAMM  =  Spatial modulation of magnetisation 
SPIOs  =  Superparamagnetic iron oxide particles 
SSFP  =  Steady-state free precession 
SV =  Stroke  volume 
TOF  =  Time of flight 
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